BAL PHARMA
|
The Current P/S Ratio of BAL PHARMA is 0.67.
Share Price | ₹135.9 | Nov 22,2024 |
Market Cap | ₹216.1 Cr | |
Sales-TTM | ₹324.3 Cr | TTM-Consolidated Results |
Price/Sales | 0.67x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of BAL PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹216.1 Cr] as on Nov 22,2024
(/) Sales [ ₹324.3 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 0.67x ]
Thus, for BAL PHARMA , the investors are currently willing to pay '0.67 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of BAL PHARMA !
The chart below summarizes the trend in P/S Ratio of BAL PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of BAL PHARMA
PS Ratio Performance Analysis for BAL PHARMA
- BAL PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.39x.
- BAL PHARMA 's operated at median p/e ratio of 0.35x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BAL PHARMA 's p/e ratio peaked in Mar2022 at 0.57x.
- BAL PHARMA 's p/e ratio hit its five-year low in Mar2020 of 0.27x.
How does BAL PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
BAL PHARMA | 324.3 | 0.67 | 216.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 8.57 | 431,352.0 |
CIPLA LTD | 26,512.0 | 4.53 | 120,035.0 |
DR REDDYS LABORATORIES LTD | 30,084.9 | 3.37 | 101,286.0 |
ZYDUS LIFESCIENCES LTD | 21,483.5 | 4.44 | 95,461.4 |
DIVIS LABORATORIES LTD | 8,614.0 | 18.49 | 159,265.0 |
MANKIND PHARMA LTD | 11,018.0 | 9.28 | 102,231.0 |
TORRENT PHARMACEUTICALS LTD | 11,225.0 | 9.56 | 107,306.0 |
LUPIN LTD | 21,431.3 | 4.41 | 94,430.6 |
AUROBINDO PHARMA LTD | 30,295.0 | 2.35 | 71,069.8 |
ABBOTT INDIA LTD | 6,066.1 | 9.70 | 58,859.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BAL PHARMA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 0.67x |
Max industry PS | 18.49x |
Median industry PS | 4.53x |
Average industry PS | 6.85x |
You may also like the below Video Courses